Literature DB >> 9040865

Splenic blood flow: evaluation with computed tomography.

M J Blomley1, M Kormano, R Coulden, J Lim-Dunham, P Dawson, M J Lipton.   

Abstract

RATIONALE AND
OBJECTIVES: To study splenic perfusion with use of computed tomography (CT).
METHODS: Twenty-six control patients without splenoportal disease, six with cirrhosis, and seven with other splenic disease were examined with electron-beam CT. Twenty-five milliliters of iohexol (300 mg of iodine per milliliter) was given intravenously at 10 mL/sec followed by a saline bolus. Multiple single-level axial sections were acquired 8-90 seconds after injection. Perfusion was calculated by dividing maximal splenic enhancement by the area under the circulation-corrected aortic time-enhancement curve. Subjective assessments of enhancement heterogeneity were made, and regional perfusion was calculated in 10 patients with heterogeneous enhancement. Total splenic volume and blood flow were computed in 21 patients.
RESULTS: Mean perfusion (controls: 1.29 mL/min/mL, miscellaneous group: 1.07 mL/min/mL) was close to predictions. There was a trend toward lower perfusion in cirrhotic patients (0.87 mL/min/mL), but the difference was not statistically significant. Total splenic blood was increased in patients with cirrhosis (P < .01). Marked perfusion heterogeneity was observed in 41% of spleens, but by 2 minutes splenic enhancement was uniform.
CONCLUSION: CT shows promise in the study of splenic blood flow.

Entities:  

Mesh:

Year:  1997        PMID: 9040865     DOI: 10.1016/s1076-6332(97)80155-9

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  7 in total

1.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

2.  Factors affecting the quantitative liver-spleen scan in normal individuals.

Authors:  John C Hoefs; Muhammad Y Sheikh; Heather Guerrero; Norah Milne
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

3.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

Review 4.  Intrapancreatic accessory spleen: findings on MR Imaging, CT, US and scintigraphy, and the pathologic analysis.

Authors:  Se Hyung Kim; Jeong Min Lee; Joon Koo Han; Jae Young Lee; Kyoung Won Kim; Kyunghee C Cho; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2008 Mar-Apr       Impact factor: 3.500

5.  Intrapancreatic accessory spleen: Evaluation with CT and MRI.

Authors:  Qianjiang Ding; Zhihao Ren; Jianhua Wang; Xiaolong Ma; Jian Zhang; Gaofeng Sun; Changjing Zuo; Hao Gu; Hui Jiang
Journal:  Exp Ther Med       Date:  2018-08-17       Impact factor: 2.447

6.  CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?

Authors:  Emina Talakić; Silvia Schaffellner; Daniela Kniepeiss; Helmut Mueller; Rudolf Stauber; Franz Quehenberger; Helmut Schoellnast
Journal:  Eur Radiol       Date:  2017-03-20       Impact factor: 5.315

7.  Spleen dynamic contrast-enhanced magnetic resonance imaging as a new method for staging liver fibrosis in a piglet model.

Authors:  Li Zhou; Tian-wu Chen; Xiao-ming Zhang; Cheng-jun Li; Zhen-feng Yang; Nan-lin Zeng; Li-ying Wang; Ting Li; Dan Wang; Jie Li; Chun-ping Li; Li Li; Xian-yong Xie
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.